Schackman, Bruce

Publications

Sort by

Co-Author Network

selected publications

Economic benefits of substance use disorder treatment: A systematic literature review of economic evaluation studies from 2003 to 2021. Journal of substance use and addiction treatment. 2023 Academic Article GET IT
Racial/Ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City. Research square. 2023 Article GET IT
Times cited: 2
Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids. JAMA health forum. 2023 Academic Article GET IT
Keep It Up! 3.0: Study protocol for a type III hybrid implementation-effectiveness cluster-randomized trial. Contemporary clinical trials. 2023 Academic Article GET IT
The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study. Harm reduction journal. 2023 Academic Article GET IT
Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island. JAMA network open. 2022 Academic Article GET IT
Times cited: 1
Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts. Drug and alcohol dependence. 2022 Academic Article GET IT
Times cited: 3
Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial. Drug and alcohol dependence reports. 2022 Academic Article GET IT
Correction: M²HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID. Trials. 2022 Article GET IT
Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021. Public health reports (Washington, D.C. : 1974). 2022 Academic Article GET IT
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives. The International journal on drug policy. 2022 Academic Article GET IT
Times cited: 2
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine. Journal of addiction medicine. 2022 Academic Article GET IT
Responding to a surge in overdose deaths: perspectives from US syringe services programs. Harm reduction journal. 2022 Academic Article GET IT
M²HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID. Trials. 2022 Academic Article GET IT
Times cited: 1
Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US Cities. Journal of acquired immune deficiency syndromes (1999). 2022 Academic Article GET IT
Times cited: 2
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020. Drug and alcohol dependence. 2022 Academic Article GET IT
Times cited: 11
Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs. Drug and alcohol dependence. 2022 Academic Article GET IT
The Experience of Implementing a Low-Threshold Buprenorphine Treatment Program in a Non-Urban Medical Practice. Substance use & misuse. 2021 Academic Article GET IT
Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction (Abingdon, England). 2021 Academic Article GET IT
Times cited: 2
Costs of opioid overdose education and naloxone distribution in New York City. Substance abuse. 2021 Academic Article GET IT
Times cited: 2
The Value and Challenge of Frequent Human Immunodeficiency Virus (HIV) Testing Among Young Men Who Have Sex With Men in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Editorial Article GET IT
Times cited: 1
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island. The International journal on drug policy. 2021 Academic Article GET IT
Times cited: 6
Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era. Medical care. 2021 Academic Article GET IT
Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. The lancet. HIV. 2021 Academic Article GET IT
Times cited: 4
Impact of Removing Medicaid Fee-for-Service Hepatitis C Virus (HCV) Treatment Restrictions on HCV Provider Experience with Medicaid Managed Care Organizations in New York City. Journal of urban health : bulletin of the New York Academy of Medicine. 2021 Academic Article GET IT
Times cited: 3
Robust Prescription Monitoring Programs and Abrupt Discontinuation of Long-term Opioid Use. American journal of preventive medicine. 2021 Academic Article GET IT
Times cited: 5
Addressing Barriers to On-site HIV and HCV Testing Services in Methadone Maintenance Treatment Programs in the United States: Findings From a National Multisite Qualitative Study. Journal of public health management and practice : JPHMP. 2021 Academic Article GET IT
Times cited: 4
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Academic Article GET IT
Times cited: 22
Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis. Addiction (Abingdon, England). 2021 Academic Article GET IT
Times cited: 1
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2021 Academic Article GET IT
Times cited: 11
Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research. Substance abuse treatment, prevention, and policy. 2021 Academic Article GET IT
Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA network open. 2021 Academic Article GET IT
Times cited: 23
A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study. Journal of general internal medicine. 2021 Academic Article GET IT
Times cited: 12
"Ending the Epidemic" Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Academic Article GET IT
Times cited: 19
Can the 'Ending the HIV Epidemic' initiative transition the USA towards HIV/AIDS epidemic control?. AIDS (London, England). 2020 Comment GET IT
Times cited: 4
Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting. JAMA network open. 2020 Academic Article GET IT
Times cited: 12
Evaluation of Alcohol Taxes as a Public Health Opportunity to Reduce Liver Transplant Listings for Alcohol-Related Liver Disease. Alcoholism, clinical and experimental research. 2020 Academic Article GET IT
Times cited: 1
Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study. Drug and alcohol dependence. 2020 Academic Article GET IT
Times cited: 7
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities. The Journal of infectious diseases. 2020 Academic Article GET IT
Times cited: 1
Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program. The Journal of infectious diseases. 2020 Academic Article GET IT
Times cited: 4
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City. The Journal of infectious diseases. 2020 Academic Article GET IT
Times cited: 11
COVID-19 Could Change the Way We Respond to the Opioid Crisis-for the Better. Psychiatric services (Washington, D.C.). 2020 Academic Article GET IT
Times cited: 16
Dissemination Science to Advance the Use of Simulation Modeling: Our Obligation Moving Forward. Medical decision making : an international journal of the Society for Medical Decision Making. 2020 Editorial Article GET IT
Times cited: 3
Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trial. Drug and alcohol dependence. 2020 Academic Article GET IT
Times cited: 8
State Policies for Prescription Drug Monitoring Programs and Adverse Opioid-related Hospital Events. Medical care. 2020 Academic Article GET IT
Times cited: 7
Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results: A Randomized Trial. Medical care. 2020 Academic Article GET IT
Times cited: 5
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Academic Article GET IT
Times cited: 6
Ending the HIV epidemic in the USA: an economic modelling study in six cities. The lancet. HIV. 2020 Academic Article GET IT
Times cited: 33
Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future. Journal of substance abuse treatment. 2020 Academic Article GET IT
Times cited: 5
Hepatitis C Treatment Uptake by New Prescribers After the Introduction of Direct Acting Antivirals. Journal of general internal medicine. 2020 Letter GET IT
Times cited: 2
The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities. AIDS (London, England). 2020 Academic Article GET IT
Times cited: 25
Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2020 Academic Article GET IT
Times cited: 4
Spatial distribution and characteristics of HIV clusters in Ethiopia. Tropical medicine & international health : TM & IH. 2020 Academic Article GET IT
Times cited: 5
The FANMI ("my FAMILY" in Creole) study to evaluate community-based cohort care for adolescent and young women living with HIV in Haiti: protocol for a randomized controlled trial. BMC public health. 2019 Academic Article GET IT
Times cited: 2
Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities. Medical decision making : an international journal of the Society for Medical Decision Making. 2019 Academic Article GET IT
Times cited: 20
Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles County. Open forum infectious diseases. 2019 Academic Article GET IT
Times cited: 4
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US Cities. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 Academic Article GET IT
Times cited: 19
Commentary on Barbosa et al. (2019): The value of using community simulation modeling to achieve HCV elimination targets in people who inject drugs. Addiction (Abingdon, England). 2019 Comment GET IT
Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review. PharmacoEconomics. 2019 Review GET IT
Times cited: 5
Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City. Journal of substance abuse treatment. 2019 Academic Article GET IT
Times cited: 18
Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?. Journal of substance abuse treatment. 2019 Academic Article GET IT
Times cited: 18
Improving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trial. Implementation science : IS. 2019 Academic Article GET IT
Times cited: 6
Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis. PloS one. 2019 Academic Article GET IT
Times cited: 25
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. The International journal on drug policy. 2019 Academic Article GET IT
Times cited: 18
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Drug and alcohol dependence. 2019 Academic Article GET IT
Times cited: 89
Cost of an HIV Medical Care Coordination Program in Los Angeles County. Journal of acquired immune deficiency syndromes (1999). 2019 Letter GET IT
Times cited: 2
Strengthening partnerships between substance use researchers and policy makers to take advantage of a window of opportunity. Substance abuse treatment, prevention, and policy. 2019 Academic Article GET IT
Times cited: 9
The projected costs and benefits of a supervised injection facility in Seattle, WA, USA. The International journal on drug policy. 2019 Academic Article GET IT
Times cited: 10
Will converting naloxone to over-the-counter status increase pharmacy sales?. Health services research. 2019 Academic Article GET IT
Times cited: 16
Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment. Addiction science & clinical practice. 2019 Academic Article GET IT
Times cited: 19
A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination. Journal of public health management and practice : JPHMP. 2019 Academic Article GET IT
Times cited: 5
Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity. Journal of public health management and practice : JPHMP. 2019 Academic Article GET IT
Times cited: 12
Why Maximizing Quality-Adjusted Life Years, rather than Reducing HIV Incidence, Must Remain Our Objective in Addressing the HIV/AIDS Epidemic. Journal of the International Association of Providers of AIDS Care. 2019 Academic Article GET IT
Times cited: 4
No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305. PloS one. 2018 Academic Article GET IT
Times cited: 3
Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse. Annals of internal medicine. 2018 Academic Article GET IT
Times cited: 37
Closing the gaps in opioid use disorder research, policy and practice: conference proceedings. Addiction science & clinical practice. 2018 Conference Paper GET IT
Times cited: 5
Cost of pharmacotherapy for opioid use disorders following inpatient detoxification. The American journal of managed care. 2018 Academic Article GET IT
Times cited: 10
Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions. Health affairs (Project Hope). 2018 Academic Article GET IT
Times cited: 52
Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. Journal of acquired immune deficiency syndromes (1999). 2018 Letter GET IT
Times cited: 15
Criminal justice measures for economic data harmonization in substance use disorder research. Health & justice. 2018 Academic Article GET IT
Times cited: 1
First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults. Journal of general internal medicine. 2018 Academic Article GET IT
Times cited: 16
Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities. AIDS and behavior. 2018 Review GET IT
Times cited: 24
The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients. Journal of Crohn's & colitis. 2018 Academic Article GET IT
Times cited: 26
Telementoring of primary care providers delivering hepatitis C treatment in New York City: Results from Project INSPIRE. Learning health systems. 2018 Academic Article GET IT
Times cited: 7
State Medicaid Hepatitis C Treatment Eligibility Criteria and Use of Direct-Acting Antivirals. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2018 Academic Article GET IT
Times cited: 18
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug and alcohol dependence. 2018 Academic Article GET IT
Times cited: 20
Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy. BMC infectious diseases. 2018 Academic Article GET IT
Times cited: 22
Treating and Preventing HIV with Generic Drugs - Barriers in the United States. The New England journal of medicine. 2018 Academic Article GET IT
Times cited: 8
Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2018 Academic Article GET IT
Times cited: 48
Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned. Substance abuse. 2018 Academic Article GET IT
When "the Cure" Is the Risk: Understanding How Substance Use Affects HIV and HCV in a Layered Risk Environment in San Juan, Puerto Rico. Health education & behavior : the official publication of the Society for Public Health Education. 2017 Academic Article GET IT
Times cited: 5
Monetary conversion factors for economic evaluations of substance use disorders. Journal of substance abuse treatment. 2017 Academic Article GET IT
Times cited: 26
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. Journal of substance abuse treatment. 2017 Academic Article GET IT
Times cited: 188
States With Prescription Drug Monitoring Mandates Saw A Reduction In Opioids Prescribed To Medicaid Enrollees. Health affairs (Project Hope). 2017 Academic Article GET IT
Times cited: 87
The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico. BMC health services research. 2017 Academic Article GET IT
Times cited: 3
Quality of life as an outcome of opioid use disorder treatment: A systematic review. Journal of substance abuse treatment. 2017 Review GET IT
Times cited: 38
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open forum infectious diseases. 2016 Academic Article GET IT
Times cited: 5
Joint Utility Estimators in Substance Use Disorders. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2016 Academic Article GET IT
Times cited: 13
Substance use and STI acquisition: Secondary analysis from the AWARE study. Drug and alcohol dependence. 2016 Academic Article GET IT
Times cited: 18
Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians. Health affairs (Project Hope). 2016 Academic Article GET IT
Times cited: 239
On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial. Trials. 2016 Academic Article GET IT
Times cited: 10
Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke. PloS one. 2016 Academic Article GET IT
Times cited: 11
Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City. Journal of acquired immune deficiency syndromes (1999). 2016 Academic Article GET IT
Times cited: 6
Costs of Expanded Rapid HIV Testing in Four Emergency Departments. Public health reports (Washington, D.C. : 1974). 2016 Academic Article GET IT
Times cited: 18
Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population. Addiction (Abingdon, England). 2015 Academic Article GET IT
Times cited: 26
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US. HIV clinical trials. 2015 Academic Article GET IT
Times cited: 3
Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice. Pharmacogenomics. 2015 Academic Article GET IT
Times cited: 17
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing. 2015 GET IT
Times cited: 131
Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment. Journal of acquired immune deficiency syndromes (1999). 2015 Academic Article GET IT
Times cited: 14
Short term health-related quality of life improvement during opioid agonist treatment. Drug and alcohol dependence. 2015 Review GET IT
Times cited: 31
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Annals of internal medicine. 2015 Academic Article GET IT
Times cited: 86
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. The International journal on drug policy. 2015 Academic Article GET IT
Times cited: 28
The lifetime medical cost savings from preventing HIV in the United States. Medical care. 2015 Academic Article GET IT
Times cited: 80
The clinical role and cost-effectiveness of long-acting antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Academic Article GET IT
Times cited: 35
Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs. Addiction (Abingdon, England). 2015 Academic Article GET IT
Times cited: 35
Performance of a mathematical model to forecast lives saved from HIV treatment expansion in resource-limited settings. Medical decision making : an international journal of the Society for Medical Decision Making. 2014 Academic Article GET IT
Times cited: 2
Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patients. Radiology. 2014 Academic Article GET IT
Times cited: 12
The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United States. Sexually transmitted diseases. 2014 Academic Article GET IT
Times cited: 18
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PloS one. 2014 Academic Article GET IT
Times cited: 104
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. AIDS (London, England). 2014 Academic Article GET IT
Times cited: 18
Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion. 2013 Academic Article GET IT
Times cited: 35
Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial. JAMA. 2013 Academic Article GET IT
Times cited: 100
Health-Related Quality of Life in HIV-Infected and At-Risk Women: The Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted Measure. Medical decision making : an international journal of the Society for Medical Decision Making. 2013 Academic Article GET IT
Times cited: 11
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Academic Article GET IT
Times cited: 37
A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health affairs (Project Hope). 2013 Academic Article GET IT
Times cited: 112
Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique. Journal of the International AIDS Society. 2013 Academic Article GET IT
Times cited: 24
AIDS Drug Assistance Programs: managers confront uncertainty and need to adapt as the Affordable Care Act kicks in. Health affairs (Project Hope). 2013 Academic Article GET IT
Times cited: 12
Lives saved by expanding HIV treatment availability in resource-limited settings: the example of Haiti. Journal of acquired immune deficiency syndromes (1999). 2013 Academic Article GET IT
Times cited: 8
Cost-effectiveness of generic antiretroviral therapy--in response. Annals of internal medicine. 2013 Letter GET IT
Times cited: 2
The value of HIV screening in the United States in the era of effective treatment. Medical decision making : an international journal of the Society for Medical Decision Making. 2013 Editorial Article GET IT
Times cited: 2
Updating the HIV-testing guidelines--a modest change with major consequences. The New England journal of medicine. 2013 Academic Article GET IT
Times cited: 21
Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Annals of internal medicine. 2013 Academic Article GET IT
Times cited: 114
Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis. Journal of the International Association of Providers of AIDS Care. 2013 Conference Paper GET IT
Times cited: 30
Appropriateness criteria and elective procedures--total joint arthroplasty. The New England journal of medicine. 2012 Academic Article GET IT
Times cited: 64
Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV disease. Antiviral therapy. 2012 Academic Article GET IT
Times cited: 11
Cost-effectiveness of pre-exposure prophylaxis for HIV: a review. Current opinion in HIV and AIDS. 2012 Review GET IT
Times cited: 53
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. Drug and alcohol dependence. 2012 Academic Article GET IT
Times cited: 28
What does U.S. health reform mean for HIV clinical care?. Journal of acquired immune deficiency syndromes (1999). 2012 Review GET IT
Times cited: 24
Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. American journal of public health. 2012 Academic Article GET IT
Times cited: 78
Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Academic Article GET IT
Times cited: 46
Inappropriate medication in a national sample of US elderly patients receiving home health care. Journal of general internal medicine. 2012 Academic Article GET IT
Times cited: 54
Inappropriate Medication in Home Health Care. Journal of general internal medicine. 2012 Academic Article GET IT
Times cited: 2
Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care. Journal of general internal medicine. 2012 Academic Article GET IT
Times cited: 73
Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults. AIDS (London, England). 2012 Academic Article GET IT
Times cited: 66
Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development. HIV clinical trials. 2012 Academic Article GET IT
Times cited: 7
Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti. PLoS medicine. 2011 Academic Article GET IT
Times cited: 28
NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs. The American journal of drug and alcohol abuse. 2011 Academic Article GET IT
Times cited: 4
Collaborative depression care management and disparities in depression treatment and outcomes. Archives of general psychiatry. 2011 Academic Article GET IT
Times cited: 42
HIV rapid testing in substance abuse treatment: implementation following a clinical trial. Evaluation and program planning. 2011 Academic Article GET IT
Times cited: 17
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation. Journal of acquired immune deficiency syndromes (1999). 2011 Academic Article GET IT
Times cited: 19
Implementation science for the prevention and treatment of HIV/AIDS. Journal of acquired immune deficiency syndromes (1999). 2010 Academic Article GET IT
Times cited: 64
Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2010 Academic Article GET IT
Times cited: 17
Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010 Academic Article GET IT
Times cited: 19
The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. Journal of viral hepatitis. 2010 Academic Article GET IT
Times cited: 26
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. The Journal of infectious diseases. 2010 Academic Article GET IT
Times cited: 171
Results from a New York City emergency department rapid HIV testing program. Journal of acquired immune deficiency syndromes (1999). 2010 Letter GET IT
Times cited: 18
Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010 Academic Article GET IT
Times cited: 51
An In-Depth Survey of the Screening and Assessment Practices of Highly Regarded Adolescent Substance Abuse Treatment Programs. Journal of child & adolescent substance abuse. 2010 Academic Article GET IT
Times cited: 10
Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164. HIV clinical trials. 2010 Academic Article GET IT
Times cited: 14
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Academic Article GET IT
Times cited: 163
Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer. Cancer. 2009 Academic Article GET IT
Times cited: 73
Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV care. AIDS care. 2009 Academic Article GET IT
Times cited: 16
Achieving effective antidepressant pharmacotherapy in primary care: the role of depression care management in treating late-life depression. Journal of the American Geriatrics Society. 2009 Academic Article GET IT
Times cited: 11
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Academic Article GET IT
Times cited: 214
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV. AIDS (London, England). 2008 Academic Article GET IT
Times cited: 136
Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts. The Journal of infectious diseases. 2008 Academic Article GET IT
Times cited: 15
Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?. Medical decision making : an international journal of the Society for Medical Decision Making. 2008 Academic Article GET IT
Times cited: 33
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects. The Journal of infectious diseases. 2008 Academic Article GET IT
Times cited: 137
Can urban methadone patients complete health utility assessments?. Patient education and counseling. 2008 Academic Article GET IT
Times cited: 1
The cost of antiretroviral therapy in Haiti. Cost effectiveness and resource allocation : C/E. 2008 Academic Article GET IT
Times cited: 125
Sexually active HIV-positive patients frequently report never using condoms in audio computer-assisted self-interviews conducted at routine clinical visits. AIDS patient care and STDs. 2008 Academic Article GET IT
Times cited: 17
Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095. Journal of acquired immune deficiency syndromes (1999). 2007 Academic Article GET IT
Times cited: 60
Preventing vertical hepatitis C virus transmission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007 Letter GET IT
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007 Academic Article GET IT
Times cited: 19
Does higher cost mean better quality? evidence from highly-regarded adolescent drug treatment programs. Substance abuse treatment, prevention, and policy. 2007 Academic Article GET IT
Times cited: 98
Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS medicine. 2007 Academic Article GET IT
Times cited: 54
Offers of hepatitis C care do not lead to treatment. Journal of urban health : bulletin of the New York Academy of Medicine. 2007 Academic Article GET IT
Times cited: 21
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. AIDS (London, England). 2007 Academic Article GET IT
Times cited: 20
Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Review GET IT
Times cited: 18
Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Annals of internal medicine. 2006 Academic Article GET IT
Times cited: 169
Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients. Journal of acquired immune deficiency syndromes (1999). 2006 Academic Article GET IT
Times cited: 42
Can hip protector use cost-effectively prevent fractures in community-dwelling geriatric populations?. Journal of the American Geriatrics Society. 2006 Academic Article GET IT
Times cited: 23
The lifetime cost of current human immunodeficiency virus care in the United States. Medical care. 2006 Review GET IT
Times cited: 359
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial. JAMA. 2006 Academic Article GET IT
Times cited: 202
The use of an educational video during informed consent in an HIV clinical trial in Haiti. Journal of acquired immune deficiency syndromes (1999). 2006 Academic Article GET IT
Times cited: 32
Response to commentary by Dr. Oliver and colleagues on hip protectors. Journal of the American Geriatrics Society. 2006 Letter GET IT
The survival benefits of AIDS treatment in the United States. The Journal of infectious diseases. 2006 Academic Article GET IT
Times cited: 483
Variations in self-rated health among patients with HIV infection. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2006 Academic Article GET IT
Times cited: 16
Design issues in initial HIV-treatment trials: focus on ACTG A5095. Antiviral therapy. 2006 Academic Article GET IT
Times cited: 11
The cost of HIV medication adherence support interventions: results of a cross-site evaluation. AIDS care. 2005 Academic Article GET IT
Times cited: 17
Variation in orthopaedic surgeons' perceptions about the indications for rotator cuff surgery. The Journal of bone and joint surgery. American volume. 2005 Academic Article GET IT
Times cited: 129
A synthesis of cost-utility analysis literature in infectious disease. The Lancet. Infectious diseases. 2005 Review GET IT
Times cited: 17
A cost-benefit analysis of external hip protectors in the nursing home setting. Journal of the American Geriatrics Society. 2005 Academic Article GET IT
Times cited: 33
Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment. Health care financing review. 2005 Academic Article GET IT
Times cited: 4
The cost-effectiveness of elective Cesarean delivery to prevent hepatitis C transmission in HIV-coinfected women. AIDS (London, England). 2004 Academic Article GET IT
Times cited: 17
The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey. Archives of pediatrics & adolescent medicine. 2004 Academic Article GET IT
Times cited: 98
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. The New England journal of medicine. 2004 Academic Article GET IT
Times cited: 484
How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?. PharmacoEconomics. 2004 Academic Article GET IT
Times cited: 21
Health-state valuations have been core issues in the field of medical decision making. Medical decision making : an international journal of the Society for Medical Decision Making. 2003 Letter GET IT
Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Archives of internal medicine. 2002 Review GET IT
Times cited: 61
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Medical decision making : an international journal of the Society for Medical Decision Making. 2002 Academic Article GET IT
Times cited: 92
Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults. American journal of public health. 2001 Academic Article GET IT
Times cited: 50

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

HEAL Data2Action Modeling and Economic Resource Center awarded by National Institute on Drug Abuse Principal Investigator 2022 - 2027
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities awarded by National Institute on Drug Abuse Principal Investigator 2020 - 2025
Simulation Modeling To Support The Public Health Response To The Opioid Crisis In North America awarded by National Institute on Drug Abuse Principal Investigator 2021 - 2024
DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND) awarded by National Institute on Drug Abuse Principal Investigator 2019 - 2024
DAT 18-06 Feasibility and Acceptability of HIV, HCV, and Opioid Use Disorder Services in Syringe Service Programs awarded by National Institute on Drug Abuse Principal Investigator 2020 - 2023
DAT 18-06 Feasibility and Acceptability of HIV, HCV, and Opioid Use Disorder Services in Syringe Service Programs awarded by National Institute on Drug Abuse Principal Investigator 2019 - 2023

Disparities in the Diffusion of Direct-Acting Antiviral Therapy for Hepatitis C among Baby Boomers: A Mixed-Methods Study awarded by National Institute of Diabetes & Digestive & Kidney Diseases Co-Investigator 2020 - 2024
Health and Economic Outcomes of Treatment with Extended-Release Naltrexone Among Pre-Release Prisoners with Opioid Use Disorder awarded by National Institute on Drug Abuse Co-Investigator 2019 - 2024
Reducing Post-Hospital Mortality in HIV-Infected Adults in Tanzania awarded by National Institute of Mental Health Co-Investigator 2018 - 2024
A Multi-Site Multi-Setting RCT of Integrated HIV Prevention and HCV Care for PWID awarded by National Institute of Environmental Health Sciences Co-Investigator 2017 - 2023

Impact of Jail-Based Methadone on Overdose, Recidivism, HIV, and Health Outcomes and Costs in New York City, 2011-2017 awarded by National Heart, Lung, & Blood Institute Co-Principal Investigator 2018 - 2024

Miami Dade County ASsessment of Phylogenics to Improve Resource Equity: MD ASPIRE awarded by National Cancer Institute Principal Investigator Subaward 2022 - 2027
HEALing Communities Study: Data Coordinating Center awarded by National Institute on Drug Abuse Principal Investigator Subaward 2019 - 2024
A pragmatic trial of two strategies for implementing an effective eHealth HIV prevention program awarded by National Institute of Mental Health Principal Investigator Subaward 2018 - 2023

more ...

less ...

Background

education and training

Ph.D., Harvard University 2001
M.B.A., Harvard University 1984
A.B., Harvard College 1980

Contact

full name

Bruce Schackman

primary email

brs2006@med.cornell.edu

VIVO Weill Cornell Medical College

Bruce Schackman Professor of Population Health Sciences

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email